Is Demerol an Opioid? Uses, Risks, and Interactions

Demerol is an opioid. Its generic name is meperidine, and it is classified as a Schedule II controlled substance in the United States, placing it in the same regulatory category as morphine and fentanyl. Meperidine is a synthetic opioid analgesic that acts on the brain’s opioid receptors to relieve moderate to severe pain, but it comes with a set of risks that have made it increasingly uncommon in modern medicine, including a toxic breakdown product that can cause seizures.

What Kind of Opioid Demerol Is

Meperidine belongs to a chemical family called phenylpiperidines, which also includes fentanyl and sufentanil. It was first synthesized in the late 1930s, originally explored as a potential antispasmodic agent, and its painkilling properties were recognized soon after. For decades it was one of the most widely prescribed opioids in hospitals, used for everything from postoperative pain to labor analgesia. Its brand name, Demerol, became almost synonymous with strong injectable pain relief in American medicine during the mid-twentieth century.¹

As an opioid, meperidine works by binding to mu-opioid receptors in the brain and spinal cord, dampening pain signals and producing the sedation and euphoria characteristic of the drug class. It also has some activity at kappa-opioid receptors.² Unlike morphine, meperidine also has local anesthetic properties, meaning it can numb tissue in a way that most other opioids cannot. This structural quirk, shared with certain local anesthetics, has given it a niche role in spinal anesthesia.³

Why Demerol Is Used Less Often Today

If Demerol is a perfectly functional painkiller, you might wonder why it has fallen out of favor. The short answer is its metabolite. When your liver processes meperidine, one of the main enzymes involved breaks it down into a substance called normeperidine. Unlike the parent drug, normeperidine is not a sedative; it is a central nervous system stimulant.⁴ Normeperidine accumulates in the body with repeated doses, and once it builds up past a certain point, it can cause tremors, muscle twitching, agitation, and full-blown tonic-clonic seizures.

This is not a theoretical concern. Case reports describe patients developing seizures even when meperidine was dosed within the recommended range. One well-documented case involved a patient who seized five days after hip revision surgery while receiving meperidine through a patient-controlled pump at standard doses. The seizure was violent enough to dislocate the surgical implant and fracture the acetabulum.⁵ Normeperidine has a long half-life, meaning it lingers in the body much longer than meperidine itself. Over several days of dosing, it quietly accumulates, and by the time seizures occur, stopping the drug does not immediately resolve the problem because the metabolite is already circulating.

Overdose with meperidine can cause respiratory depression, dangerously low blood pressure, and coma, just like other opioids. But it also adds the risk of delirium and seizures from normeperidine accumulation, making the clinical picture more complicated than a typical opioid overdose.² Standard opioid reversal with naloxone will address the respiratory depression but will not reverse the seizure-causing effects of normeperidine, because those effects are not mediated through opioid receptors. This is something emergency physicians have to keep in mind when treating a meperidine overdose.

The Interaction That Changed American Medicine

The most dangerous drug interaction involving Demerol is with a class of antidepressants called monoamine oxidase inhibitors, or MAOIs. Combining meperidine with an MAOI can trigger serotonin syndrome, a potentially fatal condition involving dangerously high body temperatures, muscle rigidity, agitation, and cardiovascular collapse. This interaction is classified among the most dangerous drug-drug combinations in clinical pharmacology.⁶

This interaction gained national attention through a tragedy. In 1984, an eighteen-year-old college student named Libby Zion was admitted to a New York City hospital with fever and agitation. She was taking phenelzine, an MAOI, for depression. Hospital staff administered Demerol to manage her agitation. Within hours, her temperature spiked uncontrollably, and she died of cardiac arrest. The interaction between meperidine and phenelzine was poorly recognized at the time.⁷

Libby Zion’s father, a lawyer and former New York Times editorialist, pushed aggressively for accountability. A grand jury considered murder charges against the treating residents and physicians, though those charges were ultimately dropped. The case became a catalyst for sweeping reforms in medical education. New York State convened the Bell Commission in 1987 to investigate resident work hours, and the resulting regulations limiting how long medical trainees could work without rest eventually spread nationwide.⁷ The case is still taught in medical schools today, often in the context of both drug interactions and systemic failures in patient supervision. It is one of the clearest examples in modern medicine of a single adverse event driving structural change in how doctors are trained.

Why Demerol Is Still Used for Shivering

Despite its declining role in pain management, meperidine has held on to one clinical niche where it outperforms other opioids: controlling postoperative and post-anesthetic shivering. Shivering after surgery or during therapeutic cooling is common and can be more than just uncomfortable. It raises oxygen consumption, increases heart rate, and can destabilize patients who are already medically fragile.

Meperidine lowers the body’s shivering threshold more effectively than other opioids, and research suggests it does so through a mechanism partly separate from its opioid receptor activity. One study found that meperidine reduced the shivering threshold roughly twice as much as the vasoconstriction threshold, suggesting a selective anti-shivering effect that goes beyond simple sedation or warming.⁸ In combination with dexmedetomidine, another sedative agent, the effects on shivering were additive, pushing the threshold down further.⁹

This anti-shivering property is why you might still encounter Demerol in a recovery room today, typically given as a single low dose rather than as a multiday pain regimen. A one-time injection sidesteps the normeperidine accumulation problem that makes repeated dosing dangerous.

Demerol in Labor and Delivery

For decades, meperidine was one of the most commonly used opioids during labor. It is still used in some settings, but the evidence on fetal and neonatal effects has made many practitioners cautious. When given to a laboring mother, meperidine crosses the placenta readily, and both meperidine and normeperidine can accumulate in fetal blood.

Research on fetal heart rate monitoring found that meperidine, compared with placebo, was associated with significantly less beat-to-beat variability, fewer accelerations, and more decelerations in fetal heart rate. About 28% of fetuses exposed to meperidine showed reduced variability, compared with 5% in the placebo group.¹⁰ These heart rate changes are concerning because they can mimic signs of fetal distress, complicating clinical decision-making about when to intervene.

The accumulation problem gets worse with longer labors. When a mother receives multiple doses of meperidine over many hours, both meperidine and normeperidine build up in fetal tissues. With longer intervals between the last dose and delivery, the ratio of normeperidine to meperidine in the fetal blood actually increases, meaning the toxic metabolite becomes a larger share of what the baby is exposed to. Elimination of both compounds by the newborn is prolonged, so the effects can linger well after birth.¹¹ Separately, a study examining neonatal outcomes after meperidine use found that the incidence of fetal or neonatal depression was higher in the meperidine group than in controls, though it did not correlate cleanly with route of administration or serum concentrations at delivery.¹²

Epidural analgesia has largely replaced systemic opioids like meperidine for labor pain in well-resourced hospitals. Where epidurals are not available or not desired, other opioids with shorter-acting metabolites have become preferred.

Who Faces the Greatest Risks

The normeperidine problem is worst in people whose bodies cannot clear the metabolite efficiently. Two groups stand out: people with kidney disease and older adults, who often overlap.

Normeperidine is cleared primarily through the kidneys. When kidney function declines, the metabolite accumulates faster, increasing the risk of neurotoxicity at any given dose. Clinical guidance is blunt on this point: meperidine should not be used in patients with chronic kidney disease who are not on dialysis, alongside morphine and codeine, which share similar clearance concerns.¹³ The risk of central nervous system excitation, including seizures, increases with longer durations of meperidine use in these patients.

Older adults are particularly vulnerable because kidney function naturally declines with age, often without obvious symptoms. An elderly patient might have lab values that look borderline normal but still clear normeperidine far more slowly than a younger patient. Combined with the fact that older adults are more sensitive to opioids in general, meperidine has largely been flagged as inappropriate for geriatric use in most clinical guidelines.

Liver disease also changes the equation, though in a different way. Meperidine undergoes extensive first-pass metabolism in the liver, and patients with hepatic cirrhosis show altered processing of both meperidine and normeperidine.¹⁴ The interplay between liver and kidney impairment can make dosing unpredictable, which is another reason clinicians have moved away from this drug in complex medical patients.

How Demerol Compares to Other Opioids

Meperidine was once considered roughly interchangeable with morphine for acute pain, but comparative studies revealed some unflattering differences. In a double-blind comparison of morphine, meperidine, fentanyl, and sufentanil during balanced anesthesia, meperidine performed the worst on several measures. Heart rates increased significantly after induction with meperidine and remained higher after intubation compared with patients receiving sufentanil. Side effects including histamine release accompanied by drops in blood pressure and rapid heart rate were most frequent and most severe in the meperidine group.¹⁵

Histamine release is particularly relevant because it can cause flushing, itching, and drops in blood pressure. While other opioids like morphine also cause some histamine release, meperidine tends to cause more. This makes it a poor choice in hemodynamically unstable patients. Early literature also cautioned against using meperidine in patients with certain cardiac arrhythmias, noting that its anticholinergic activity could speed heart rate and worsen conditions like atrial flutter.¹⁶

The anticholinergic effects deserve a mention because they set meperidine apart from most opioids. Besides speeding up heart rate, anticholinergic activity can cause dry mouth, urinary retention, and confusion, particularly in older adults who may already be taking other drugs with anticholinergic properties. This stacking effect is another reason geriatric specialists have largely abandoned meperidine.

Meperidine’s Unusual Local Anesthetic Property

One genuinely distinctive feature of meperidine is its ability to produce local anesthesia. Most opioids have no meaningful local anesthetic effect, but meperidine’s chemical structure is close enough to classical local anesthetics that it can block sodium channels in nerve tissue, numbing the area where it is injected. This property has been exploited in spinal anesthesia, where meperidine can provide both pain relief through opioid receptor activation and surgical-grade numbness through its local anesthetic action.³

This dual mechanism made spinal meperidine attractive in certain clinical scenarios, particularly in resource-limited settings where separate local anesthetic agents might not be readily available. In practice, however, the availability of safer and more predictable local anesthetics and spinal opioids has limited this application. It remains more of a pharmacological curiosity than a first-line technique, but it illustrates how meperidine’s chemistry differs meaningfully from other opioids in the same class.

Drug Interactions Beyond MAOIs

The MAOI interaction is the most dramatic, but meperidine has other interaction concerns worth knowing about. Any drug that increases serotonin activity can theoretically raise the risk of serotonin syndrome when combined with meperidine. This includes common antidepressants like SSRIs and SNRIs, the antibiotic linezolid (which has weak MAOI activity), and the herbal supplement St. John’s wort. The risk is generally lower than with classical MAOIs, but it is not zero, and clinicians are expected to screen for these combinations.

Drugs that inhibit the liver enzymes responsible for breaking down meperidine (CYP2B6, CYP3A4, and CYP2C19) can slow its metabolism and potentially alter the balance between meperidine and normeperidine in the blood.⁴ Common inhibitors of these enzymes include certain antifungals, some HIV medications, and grapefruit juice in large quantities. Like all opioids, meperidine also has additive sedating effects with benzodiazepines, alcohol, and other central nervous system depressants, increasing the risk of respiratory depression.

When Demerol Might Still Be Prescribed

Given everything above, you might wonder why meperidine has not been pulled from the market entirely. It has not because it still has a narrow window of legitimate use. Short-term, single-dose administration for postoperative shivering remains common. Some protocols still include it for acute rigors during blood transfusion reactions or drug-related febrile reactions. In these scenarios, the normeperidine accumulation problem is essentially moot because the drug is given once, not repeatedly.

Where meperidine has been most aggressively eliminated is in chronic pain management and prolonged postoperative analgesia. Many hospitals have removed it from their formularies or restricted its use to specific indications. The American Pain Society, along with various hospital safety organizations, has advised against routine use for pain management for years. If you are prescribed meperidine today, it is likely for a very specific, short-term reason, and your provider should be able to explain why an alternative opioid was not chosen.

For patients who are told they will receive Demerol, it is reasonable to ask whether you have any kidney or liver problems that might affect clearance, whether you take any antidepressants or medications that interact with it, and whether a single dose or multiple doses are planned. These three questions address the most important safety variables. If the answer to the first two is no and the plan is a single dose for shivering or a brief procedural use, the risk profile is quite different from the multiday regimens that generated most of the safety concerns.

1
Cambridge University Press / Duke Scholars. Essence of Analgesia and Analgesics: Meperidine
2
Oxford Academic (Journal of Analytical Toxicology). Factors Impacting Variability of the Urinary Normeperidine-to-Meperidine Metabolic Ratio in Patients with Chronic Pain
3
PubMed. Spinal anesthesia with meperidine: will epinephrine prolong its duration
4
Drug Metabolism and Disposition. CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES – Section: Abstract
5
Elsevier / PubMed Central. Meperidine-induced seizure after revision hip arthroplasty
6
PubMed. “Prescribers Beware”: a narrative review of dangerous drug-drug-interactions involving psychotropic medications
7
The Journal of Thoracic and Cardiovascular Surgery. Evidence and resident physician duty hours: Should scientific experiments be more suspect than universal implementation of an untested practice?
8
PubMed. Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold – Section: RESULTS
9
PubMed. Dexmedetomidine and meperidine additively reduce the shivering threshold in humans
10
PubMed Central. The Effects of Meperidine Analgesia during Labor on Fetal Heart Rate – Section: Abstract
11
American Journal of Obstetrics and Gynecology. Disposition of meperidine and normeperidine following multiple doses during labor: II. Fetus and neonate – Section: Abstract
12
Neonatology. Cord and Maternal Serum Meperidine Concentrations and Clinical Status of the Infant – Section: Abstract
13
PubMed Central. Opioid Management in Older Adults with Chronic Kidney Disease: A Review
14
PubMed. Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects
15
PubMed. Comparison of morphine, meperidine, fentanyl, and sufentanil in balanced anesthesia: a double-blind study
16
American Heart Journal. Caution against the use of meperidine hydrochloride (isonipecaine, demerol) in patients with heart disease, particularly auricular flutter – Section: Abstract